U.S. Hot Stocks: Hot Stocks to Watch
July 13 2016 - 8:36AM
Dow Jones News
Among the companies with shares expected to trade actively in
Wednesday's session are Diamondback Energy Inc. (FANG), Imprivata
Inc. (IMPR) and American Airlines Group Inc. (AAL).
Diamondback Energy Inc. said Wednesday that it was buying energy
assets in Texas for $560 million and raised its production guidance
for the year. Shares fell 3.22% to $89.00 in premarket trading.
Health-care IT security company Imprivata Inc. said Wednesday
that it was being acquired and taken private by private-equity firm
Thoma Bravo for $544 million, or $19.25 a share. Shares rose 32% to
$19.14 premarket.
American Airlines Group Inc. reported that its passenger traffic
rose 2.2% in June from a year earlier as capacity also climbed, and
the company narrowed its unit revenue forecast. Shares rose 1.27%
to $35.10 premarket.
Teva Pharmaceutical Industries Ltd. (TEVA) and Allergan PLC on
Wednesday said they had tweaked the terms of Teva's purchase of
Allergan's generics business, including pushing back a key date
that illustrates how long the deal is taking to close. Teva shares
rose 3.34% to $54.24 premarket.
IHS Markit Ltd. (INFO) issued guidance Wednesday as a combined
company, after having announced a day earlier the merger of IHS
Inc. and Markit Ltd. was complete.
AAR Corp. (AIR) on Tuesday gave financial guidance for its new
fiscal year that missed analysts' estimates, though the aviation
and defense services company reported that revenue rose 10% for its
latest quarter.
The Federal Trade Commission has requested additional
information from Abbott Laboratories (ABT) and St. Jude Medical
Inc. (STJ), which are attempting to close a $25 billion deal
combining two of the leading makers of heart-related devices.
Chubb Ltd. (CB) on Tuesday raised its projection for catastrophe
losses in the June quarter to $390 million, before taxes, citing
devastating natural disasters, including the Fort McMurray
wildfires in Canada. It had previously projected $280 million.
Juno Therapeutics Inc. (JUNO) will resume a drug trial of a
potential leukemia treatment that had been placed on clinical hold
last week following two patient deaths. Juno said the deaths were
likely caused by the combination of its treatment with fludarabine,
a chemotherapy drug, and will resume enrollment without
fludarabine.
Teva Pharmaceutical Industries Ltd. (TEVA), which is working
toward a $40.5 billion acquisition of Allergan PLC's generics unit,
on Tuesday raised its second-quarter financial guidance.
United Continental Holdings Inc. (UAL) will book more than $400
million in charges in the June quarter tied to a move by federal
regulators this year to open Newark Liberty International Airport
to more competition.
Write to Chris Wack at chris.wack@wsj.com or Maria Armental at
maria.armental@wsj.com
(END) Dow Jones Newswires
July 13, 2016 09:21 ET (13:21 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
IMPRIVATA INC (NYSE:IMPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMPRIVATA INC (NYSE:IMPR)
Historical Stock Chart
From Jul 2023 to Jul 2024